MIM Pharma’s system-biology-based pharmaceutical composition comprising a mixture of medical plant extracts as active ingredients, and use of said composition as a medicament, particularly in the treatment of human coronavirus infections such as COVID-19 has been published under the patent cooperation treaty (PCT).

International Publication Number WO 2022/250542